课题基金 / 基金详情

Study for the Abnormality of Intracellular Ca^<2+> Regulation in Failing Hearts

Study for the Abnormality of Intracellular Ca^<2+> Regulation in Failing Hearts
衰竭心脏细胞内Ca^<2>调节异常的研究
批准号:
13670701
负责人:
SATOH Hiroshi
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

SATOH Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In cardiac myocytes the Ca-induced Ca release from the sarcoplasmicr reticulum (SR) plays pivotal roles in Ca transients. FK-506 binding protein (FKBP) binds to the SR Ca release channels (ryanodine receptors : RyRs) and stabilizes the SR Ca release channel gating. Recent bilayer studies showed that an immunosuppressant agent, FK506 can dissociate FKBP from RyRs, thereby increasing SR Ca leak. Although the displacement of FKBP is an important aspect in failing heart, its relevance to physiological Ca regulation is still undefined. We examined the effects of FK506 on steady-state (SS) twitch Ca transients (CaT), post rest (PR) caffeine-induced CaT (as an index of SR Ca content) and Ca sparks (as an index of SR Ca leak) using laser scanning confocal microscopy and fluo-3 in rat ventricular myocytes. (1) In intact myocytes, FK506 (50 μM) increased SS (0.5Hz) twitch CaT amplitude and Ca spark frequency during rest periods, but did not change the PR twitch- and caffeine- CaT. (2) In myocytes treated either with thapsigargin and low extracellular Ca concentration, FK506 did not change the SS twitch and PR caffeine CaTs, and (3) In myocytes treated with both thapsigargin and low extracellular Ca concentration, SS twitch CaT and PR caffeine CaT largely reduced, and FK506 significantly accelerated the reduction. In conclusion, the SR Ca leak by displacement of FKBP from RyRs may not be enough to disturb normal excitation-contraction coupling in intact myocytes. However, when the SR Ca uptake was reduced and the sarcolemmal Ca extrusion was, the displacement could induce a significant SR Ca loss.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Kazuyuki Ohnishi: "Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia : need for careful electrocardiogram monitoring"Leukemia. 16. 617-622 (2002)
Kazuyuki Ohnishi:“三氧化二砷治疗复发或难治性日本急性早幼粒细胞白血病患者:需要仔细心电图监测”白血病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroshi Satoh: "Involvement of Na^+/Ca^<2+> exchange in normal cardiac excitation-contraction coupling and in Ca^<2+> overload during ischemia and reperfusion"Myocardial Ischemia and Preconditioning. In Press.
Hiroshi Satoh:“Na ^ /Ca ^ 2 交换参与正常心脏兴奋-收缩耦合以及缺血和再灌注期间的Ca ^ 2 超载”心肌缺血和预处理。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Noriyuki Nomura: "CaMKII-dependent reactivation of SR Ca^<2+> uptake and contractile recovery during intracellular acidosis"American Journal of Physiology Heart Circ Physiol. 283. 193-203 (2002)
Noriyuki Nomura:“细胞内酸中毒期间 SR Ca^<2> 摄取和收缩恢复的 CaMKII 依赖性再激活”美国生理学杂志 Heart Circ Physiol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroshi Watanabe: "Sildenafil for primary and secondary pulmonary hypertension"Clin.Pharmacol.Ther.. 71. 398-402 (2002)
Hiroshi Watanabe:“西地那非治疗原发性和继发性肺动脉高压”Clin.Pharmacol.Ther.. 71. 398-402 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
17
    Study for intracellular direct effects of renin-angiotensin system in diabetic hearts
    • 批准号:
      22590776
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2010
    • 负责人:
      SATOH Hiroshi
    • 依托单位:
    Mother-to-child kinetics and exposure assessment model for co-exposure to methylmercury and POPs during perinatal periods
    • 批准号:
      21249039
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $27.96万
    • 财政年份:
      2009
    • 负责人:
      SATOH Hiroshi
    • 依托单位:
    Does selenium deficiency deteriorate the effects of methylmercury exposure?
    • 批准号:
      18209022
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.12万
    • 财政年份:
      2006
    • 负责人:
      SATOH Hiroshi
    • 依托单位:
    Resumption of intracellular Ca2+ cycling as a novel therapeutic strategy for heart failure
    • 批准号:
      17590717
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.66万
    • 财政年份:
      2005
    • 负责人:
      SATOH Hiroshi
    • 依托单位:
    海外基金